Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus

Kidney International

Volumn 75, Issue 4, 2009, Pages 366-372

  Chan, Ka T ^a   Papeta, Natalia ^a   Martino, Jeremiah ^a   Zheng, Zongyu ^a   Frankel, Rachelle Z ^a   Klotman, Paul E ^b   D'Agati, Vivette D ^a   Lifton, Richard P ^c   Gharavi, Ali G ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genetic susceptibility; HIV associated nephropathy; Mouse model

Indexed keywords

ALLELE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACKCROSSING; BIOCHEMISTRY; CHROMOSOME 3; COLLAPSING GLOMERULOPATHY; CONGENIC STRAIN; CONTROLLED STUDY; DISEASE COURSE; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME; GLOMERULOPATHY; GLOMERULOSCLEROSIS; KIDNEY FAILURE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RISK ASSESSMENT; TISSUE SECTION;

EID: 59149094755     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.625     Document Type: Article

References (47)

1. Han TM, Naicker S, Ramdial PK et al. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 2006; 69: 2243-2250.
2. Gerntholtz TE, Goetsch SJ, Katz I. HIV-related nephropathy: a South African perspective. Kidney Int 2006; 69: 1885-1891.
3. Kiryluk K, Martino J, Gharavi AG. Genetic susceptibility, HIV infection, and the kidney. Clin J Am Soc Nephrol 2007; 2(Suppl 1): S25-S35.
4. D'Agati VD. Podocyte injury in focal segmental glomerulosclerosis: lessons from animal models (a play in five acts). Kidney Int 2008; 73: 399-406.
5. D'Agati V, Appel GB. HIV infection and the kidney. J Am Soc Nephrol 1997; 8: 138-152.
6. Albaqumi M, Soos TJ, Barisoni L et al. Collapsing glomerulopathy. J Am Soc Nephrol 2006; 17: 2854-2863.
7. Winston JA, Bruggeman LA, Ross MD et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344: 1979-1984.
8. Bruggeman LA, Ross MD, Tanji N et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000; 11: 2079-2087.
9. Barisoni L, Bruggeman LA, Mundel P et al. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 2000; 58: 173-181.
10. He JC, Husain M, Sunamoto M et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 2004; 114: 643-651.
11. Martinka S, Bruggeman LA. Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy. Am J Physiol Renal Physiol 2006; 290: F657-F665.
12. Ross MJ, Martinka S, D'Agati VD et al. NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J Am Soc Nephrol 2005; 16: 2403-2411.
13. Tandon R, Levental I, Huang C et al. HIV infection changes glomerular podocyte cytoskeletal composition and results in distinct cellular mechanical properties. Am J Physiol Renal Physiol 2007; 292: F701-F710.
14. Lu TC, He JC, Wang ZH et al. HIV-1 Nef Disrupts the Podocyte Actin Cytoskeleton by Interacting with Diaphanous Interacting Protein. J Biol Chem 2008; 283: 8173-8182.
15. Sunamoto M, Husain M, He JC et al. Critical role for Nef in HIV-1-induced podocyte dedifferentiation. Kidney Int 2003; 64: 1695-1701.
16. Husain M, D'Agati VD, He JC et al. HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 2005; 19: 1975-1980.
17. Zhong J, Zuo Y, Ma J et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 2005; 68: 1048-1060.
18. Zuo Y, Matsusaka T, Zhong J et al. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J Am Soc Nephrol 2006; 17: 2832-2843.
19. Smith MW, Dean M, Carrington M et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997; 277: 959-965.
20. Gonzalez E, Kulkarni H, Bolivar H et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307: 1434-1440.
21. Moore CB, John M, James IR et al. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296: 1439-1443.
22. Corder EH, Robertson K, Lannfelt L et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998; 4: 1182-1184.
23. US Renal Data System. USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2007.
24. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999; 55: 1036-1040.
25. Freedman BI, Soucie JM, Stone SM et al. Familial clustering of end-stage renal disease in blacks with HIV- associated nephropathy. Am J Kidney Dis 1999; 34: 254-258.
26. Kao WH, Klag MJ, Meoni LA, et al., Family Investigation of Nephropathy and Diabetes Research Group. MYH9 is associated with nondiabetic endstage renal disease in African Americans. Nat Genet 2008; 40: 1185-1192.
27. Kopp JB, Smith MW, Nelson GW et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40: 1175-1184.
28. Kopp JB, Klotman ME, Adler SH et al. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 1992; 89: 1577-1581.
29. Gharavi AG, Ahmad T, Wong RD et al. Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci USA 2004; 101: 2488-2493.
30. Abiola O, Angel JM, Avner P, et al., Complex Trait Consortium. The nature and identification of quantitative trait loci: a community's view. Nat Rev Genet 2003; 4: 911-916.
31. Darvasi A. Experimental strategies for the genetic dissection of complex traits in animal models. Nat Genet 1998; 18: 19-24.
32. Kopp JB, Rooney JF, Wohlenberg C et al. Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. AIDS Res Hum Retroviruses 1993; 9: 267-275.
33. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
34. Frazer KA, Eskin E, Kang HM et al. A sequence-based variation map of 8.27 million SNPs in inbred mouse strains. Nature 2007; 448: 1050-1053.
35. Zheng Z, Pavlidis P, Chua S et al. An ancestral haplotype defines susceptibility to doxorubicin nephropathy in the laboratory mouse. J Am Soc Nephrol 2006; 17: 1796-1800.
36. Kim JM, Wu H, Green G et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003; 300: 1298-1300.
37. Henderson JM, Al-Waheeb S, Weins A et al. Mice with altered alpha-actinin-4 expression have distinct morphologic patterns of glomerular disease. Kidney Int 2008; 73: 741-750.
38. D'Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 2003; 23: 117-134.
39. Markowitz GS, Appel GB, Fine PL et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 2001; 12: 1164-1172.
40. Avila-Casado MC, Vargas-Alarcon G, Soto ME et al. Familial collapsing glomerulopathy: clinical, pathological and immunogenetic features. Kidney Int 2003; 63: 233-239.
41. Ghiggeri GM, Caridi G, Magrini U et al. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). Am J Kidney Dis 2003; 41: 95-104.
42. Matsushita T, Hayashi H, Kunishima S et al. Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice. Biochem Biophys Res Commun 2004; 325: 1163-1171.
43. Mhatre AN, Li Y, Bhatia N et al. Generation and characterization of mice with Myh9 deficiency. Neuromolecular Med 2007; 9: 205-215.
44. Barisoni L, Madaio MP, Eraso M et al. The kd/kd mouse is a model of collapsing glomerulopathy. J Am Soc Nephrol 2005; 16: 2847-2851.
45. Peng M, Falk MJ, Haase VH et al. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease. PLoS Genet 2008; 4: e1000061.
46. Wharram BL, Goyal M, Wiggins JE et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005; 16: 2941-2952.
47. Broman KW, Wu H, Sen S et al. R/qtl: QTL mapping in experimental crosses. Bioinformatics 2003; 19: 889-890.